M&A Deal Summary

Abbott Laboratories Acquires Advanced Medical Optics

On January 12, 2009, Abbott Laboratories acquired medical products company Advanced Medical Optics for 2.8B USD

Acquisition Highlights
  • This is Abbott Laboratories’ 8th transaction in the Medical Products sector.
  • This is Abbott Laboratories’ 9th largest (disclosed) transaction.
  • This is Abbott Laboratories’ 13th transaction in the United States.
  • This is Abbott Laboratories’ 5th transaction in California.

M&A Deal Summary
Date 2009-01-12
Target Advanced Medical Optics
Sector Medical Products
Buyer(s) Abbott Laboratories
Deal Type Add-on Acquisition
Deal Value 2.8B USD
Advisor(s) Goldman Sachs
UBS Investment Bank (Financial)
Skadden, Arps, Slate, Meagher & Flom (Legal)

Target

Advanced Medical Optics

Santa Ana, California, United States
Advanced Medical Optics Inc. (AMO) offers a range of refractive technologies for myopia, hyperopia, astigmatism, presbyopia, cataract, spherical aberration and corneal health.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Abbott Laboratories

North Chicago, Illinois, United States
Category Company
Founded 1888
Sector Medical Products
Employees114,000
Revenue 40.1B USD (2023)
DESCRIPTION
Entrance to Abbott's corporate campus in Abbott Park, Illinois.
Entrance to Abbott's corporate campus in Abbott Park, Illinois.

Abbott Laboratories is a diversified, global provider of diagnostics, medical devices, nutrition and pharmaceuticals. Abbott Laboratories was incorporated in 1888 and is headquartered in North Chicago, Illinois.

DEAL STATS #
Overall 15 of 35
Sector (Medical Products) 8 of 20
Type (Add-on Acquisition) 15 of 35
State (California) 5 of 14
Country (United States) 13 of 28
Year (2009) 2 of 5
Size (of disclosed) 9 of 28
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-01-06 Ibis Biosciences

Carlsbad, California, United States

Ibis Biosciences, Inc. is a molecular diagnostics business.

Buy $175M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-09-10 Evalve

Menlo Park, California, United States

Evalve, Inc. designs, develops, manufactures and markets innovative devices to enable percutaneous repair of cardiac valves. The company's initial products are intended to reduce the risks, trauma and cost associated with current open, arrested heart surgical options. The company's present development and clinical efforts are focused on mitral valve repair with the MitraClip system.

Buy $410M
Mergr

Product

Company

Legal